A fixed-dose 24-hour regimen of artesunate plus sulfamethoxypyrazine-pyrimethamine for the treatment of uncomplicated Plasmodium falciparum malaria in eastern Sudan

Annals of Clinical Microbiology and Antimicrobials

Volumn 5, Issue , 2006, Pages

  Adam, Ishag ^a,f   Magzoub, Mamoun ^b   Osman, Maha E ^c   Khalil, Insaf F ^d   Alifrangis, Michael ^d   Elmardi, Khalid A ^e  

^a UNIVERSITY OF KHARTOUM   (Sudan)

^b University of Kassala   (Sudan)

^c National Center for Research   (Sudan)

^d UNIVERSITY OF COPENHAGEN   (Denmark)

^e Ministry of Health   (Sudan)

^f Academy of Medical Sciences and Technology Sudan   (Sudan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; ARTESUNATE; ARTESUNATE PLUS METAKELFIN; METAKELFIN; UNCLASSIFIED DRUG; ARTEMISININ DERIVATIVE; PYRIMETHAMINE; SESQUITERPENE; SULFALENE;

ADOLESCENT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DIZZINESS; DOSE RESPONSE; DRUG CHOICE; DRUG COST; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG FORMULATION; DRUG SAFETY; FOLLOW UP; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALARIA; NAUSEA; PATIENT COMPLIANCE; PLASMODIUM FALCIPARUM; POLYMERASE CHAIN REACTION; PRURITUS; SINGLE DRUG DOSE; SUDAN; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE; VOMITING; ADULT; ANIMAL; CHILD; COMPARATIVE STUDY; DRUG ADMINISTRATION; DRUG COMBINATION; GENETICS; ISOLATION AND PURIFICATION; MALARIA, FALCIPARUM; PATIENT SELECTION; RECURRENT DISEASE; TREATMENT FAILURE;

ADULT; ANIMALS; ANTIMALARIALS; ARTEMISININS; CHILD; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; GENOTYPE; HUMANS; MALARIA, FALCIPARUM; PATIENT SELECTION; PLASMODIUM FALCIPARUM; PYRIMETHAMINE; RECURRENCE; SESQUITERPENES; SUDAN; SULFALENE; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 33748628845     PISSN: 14760711     EISSN: 14760711     Source Type: Journal    
DOI: 10.1186/1476-0711-5-18     Document Type: Article

References (23)

1. Snow RW, Guerra CA, Noor AM, Myint HY, Hay SI: The global distribution of clinical episodes of Plasmodium falciparum malaria. Nature 2005, 434:214-217.
2. World Health Organization: A global strategy for malaria control. Geneva: WHO; 1993.
3. Zucker JR, Ruebush TK, Obonyo C, Otieno J, Campbell CC: The mortality consequences of the continued use of chloroquine in Africa. experience in Siaya, western Kenya. Am J Trop Med Hyg 2003, 68:386-390.
4. Malik EM, Khalafalla OM: Malaria in Sudan: past, present and the future. Gezira Journal of Health Sciences 2004, 1(suppl):47-51.
5. Adam I, Osman ME, ElGhazali G, Ahmed GI, Gustafson LL, Elbashir MI: Efficacies of chloroquine, sulphadoxine-pyrimethamine andquinine for the treatment of uncomplicated Plasmodium falciparum malaria in Eastern Sudan. Ann Trop Med Parasitol 2004, 98:661-666.
6. Devriendt A, Jansen F, Weemaes J: Pharmacokinetics of Sulfamethoxypyrazine (Kelfizine). Effects of a single oral dose. Eur J Clin Pharmol 1970, 3:36-42.
7. Dua VK, Sarin R, Gupta NC, Sharma VP: Sulfalene concentrations in plasma and blood cells of Plasmodium falciparum malaria cases after treatment with metakelfin using high-performance liquid chromatography. J Chromat Biom Scien Applic 1988, 714:390-394.
8. Molta NB, Daniel HI, Watila IM, Oguche SO, out TI, Ameh JO, Gadzama NM: Efficacies of chloroquine, pyrimethamine/sulphadoxine and pyrimethamine/ sulphalene against P. falciparum in northeastern Nigeria. J Trop Med Hyg 1992, 95:253-259.
9. Hagos B, Khan B, Ofulla AV, Kariuki D, Martin SK: Response of falciparum malaria to chloroquine and three second line antimalarial drugs in a Kenyan coastal school age population. East Afr Med J 1993, 70:620-623.
10. Matteelli A, Saleri N, Bisoffi Z, Gregis G, Gaiera G, Visona R, Tedoldi S, Scolari C, Marocco S, Gulletta M: Mefloquine versus quinine plus sulphalene-pyrimethamine (metakelfin) for treatment of uncomplicated imported falciparum malaria acquired in Africa. Antimicr Agents Chemoth 2005, 49:663-667.
11. Al Gadal AA: Malaria in the Sudan. In Proceedings of the Conference on Malaria in Africa Edited by: Buck AA. Washington DC: American Institute of Biological Sciences; 1986:156-159.
12. World Health Organization: Assessment of therapeutic efficacy of antimalarial drugs for uncomplicated falciparum malariain areas with intense transmission. In Document WHO/MAL/96.1077 Geneva: WHO; 1996.
13. Plowe CV, Djimde A, Bouare M, Doumbo O, Wellems TE: Pyrimethamine and proguanil resistance conferring mutationsin Plasmodium falciparum dihydrofolate reductase: polymerasechain reaction methods for surveillance in Africa. Amer J Trop Med Hyg 1995, 5:565-568.
14. Snounou G, Zhu X, Siripoon N, Jarra W, Thaithong S, Brown KN, Viriyakosol S: Biased distribution of msp1 and msp2 allelic variants in Plasmodium falciparum populations in Thailand. Trans R Soc Trop Med Hyg 1999, 93:369-374.
15. WHO: Assessment and Monitoring of Antimalarial DrugEfficacy for the treatment of uncomplicated Falciparum malaria. WHO/HTM/RBM/2003.50 2003.
16. Picq JJ, Roux J, Charmot G, Lafaye A, Ricosse JH: Duration of action of the pyrimethamine-sulfamethopyrazine combination in a Plasmodium falciparum endemic zone. Bull Soc Pathol Exot Filiales 1975, 68:61-67.
17. Abdel-Humeed AA: Malaria case management at the community level in Gezira Sudan. Afr J Med Sc 2001, 30:43-46.
18. White NJ: Antimalarial drug resistance and combination chemotherapy. Philos Trans R Soc Lond B Biol Sci 1999, 354:739-749.
19. Bunnag D, Kanda T, Karbwang J, Thimasarn K, Pungpak S, Harinasuta T: Arternether-mefloquine combination in multidrug resistant falciparum malaria. Trans R Soc Trop Med Hyg 1995, 89:213-215.
20. Elamin SB, Malik EM, Abdelgadir T, Khamiss AH, Mohammed MM, Ahmed ES, Adam I: Artesunate plus sulfadoxine-pyrimethamine for treatment of uncomplicated Plasmodium falciparum malaria in Sudan. Malaria J 2005, 14(4):41.
21. Adam I, Elbasit I, Idris SM, Malik EM, Elbashir MI: A comparison of the efficacies of artesunate plus sulfadoxine-pyrimethamine versus sulfadoxine-pyrimethamine alone, in the treatment of uncomplicated Plasmodium falciparum malaria in eastern Sudan. Ann Trop Med Parasitol 2005, 99:449-455.
22. Adam I, Salih I, Elbashir MI: Quinine for the treatment of uncomplicated Plasmodium falciparum malaria in eastern Sudan. Trans R Soc Trop Med Hyg 2005, 90:736-738.
23. Nosten F, Brasseur P: Combination therapy for malaria: the way forward? Drugs 2002, 62:1315-1329.